Health11 hours ago
Boehringer Ingelheim Licenses Innovative Autoimmune Treatment from Kyowa Kirin
Boehringer Ingelheim has acquired a license from Kyowa Kirin Co., Ltd. to develop a novel treatment targeting autoimmune diseases. This agreement, announced on October 30, 2025,...